Hansoh Pharmaceutical Group Company Statistics

Total Valuation

Hansoh Pharmaceutical Group Company has a market cap or net worth of HKD 126.70 billion. The enterprise value is 101.58 billion.

Market Cap	126.70B
Enterprise Value	101.58B

Important Dates

The next estimated earnings date is Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	Sep 20, 2024

Share Statistics

Hansoh Pharmaceutical Group Company has 5.93 billion shares outstanding. The number of shares has increased by 1.34% in one year.

Shares Outstanding	5.93B
Shares Change (YoY)	+1.34%
Shares Change (QoQ)	-2.45%
Owned by Insiders (%)	15.55%
Owned by Institutions (%)	9.33%
Float	1.11B

Valuation Ratios

The trailing PE ratio is 26.21 and the forward PE ratio is 28.80. Hansoh Pharmaceutical Group Company's PEG ratio is 4.34.

PE Ratio	26.21
Forward PE	28.80
PS Ratio	9.73
PB Ratio	4.23
P/FCF Ratio	26.65
PEG Ratio	4.34

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.38, with an EV/FCF ratio of 21.37.

EV / Earnings	20.05
EV / Sales	7.81
EV / EBITDA	20.38
EV / EBIT	22.29
EV / FCF	21.37

Financial Position

The company has a current ratio of 7.98, with a Debt / Equity ratio of 0.00.

Current Ratio	7.98
Quick Ratio	7.70
Debt / Equity	0.00
Debt / EBITDA	0.03
Debt / FCF	0.03
Interest Coverage	103.73

Financial Efficiency

Return on equity (ROE) is 18.10% and return on invested capital (ROIC) is 9.34%.

Return on Equity (ROE)	18.10%
Return on Assets (ROA)	8.33%
Return on Capital (ROIC)	9.34%
Revenue Per Employee	1.43M
Profits Per Employee	556,695
Employee Count	9,123
Asset Turnover	0.38
Inventory Turnover	1.81

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +107.69% in the last 52 weeks. The beta is 0.61, so Hansoh Pharmaceutical Group Company's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	+107.69%
50-Day Moving Average	19.23
200-Day Moving Average	16.34
Relative Strength Index (RSI)	58.11
Average Volume (20 Days)	9,911,824

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hansoh Pharmaceutical Group Company had revenue of HKD 13.00 billion and earned 5.07 billion in profits. Earnings per share was 0.81.

Revenue	13.00B
Gross Profit	11.83B
Operating Income	4.56B
Pretax Income	5.79B
Net Income	5.07B
EBITDA	4.96B
EBIT	4.56B
Earnings Per Share (EPS)	0.81

Full Income Statement

Balance Sheet

The company has 25.25 billion in cash and 128.59 million in debt, giving a net cash position of 25.12 billion or 4.23 per share.

Cash & Cash Equivalents	25.25B
Total Debt	128.59M
Net Cash	25.12B
Net Cash Per Share	4.23
Equity (Book Value)	29.98B
Book Value Per Share	5.05
Working Capital	25.76B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.00 billion and capital expenditures -245.85 million, giving a free cash flow of 4.75 billion.

Operating Cash Flow	5.00B
Capital Expenditures	-245.85M
Free Cash Flow	4.75B
FCF Per Share	0.80

Full Cash Flow Statement

Margins

Gross margin is 91.01%, with operating and profit margins of 35.06% and 38.97%.

Gross Margin	91.01%
Operating Margin	35.06%
Pretax Margin	44.51%
Profit Margin	38.97%
EBITDA Margin	38.16%
EBIT Margin	35.06%
FCF Margin	36.57%

Dividends & Yields

This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 1.88%.

Dividend Per Share	0.40
Dividend Yield	1.88%
Dividend Growth (YoY)	184.34%
Years of Dividend Growth	n/a
Payout Ratio	13.83%
Buyback Yield	-1.34%
Shareholder Yield	0.54%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Hansoh Pharmaceutical Group Company has an Altman Z-Score of 14.34.

Altman Z-Score	14.34
Piotroski F-Score	n/a